HCPCS M1209: Multiple High-Risk Medication Orders from Same Class - OpenPayer

Summary & Overview

HCPCS M1209: Multiple High-Risk Medication Orders from Same Class

HCPCS Level II code M1209 flags situations where a patient has at least two orders for high‑risk medications from the same drug class without accompanying diagnoses that justify the combined use. Nationally, this code is used to highlight potential medication safety concerns, prescribing errors, or documentation gaps that can increase adverse drug event risk, particularly in older adults and medically complex patients. The code supports quality review, utilization management, and pharmacy oversight across outpatient, ambulatory, and long‑term care settings.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical focus and typical service settings, plus an outline of what to expect in benchmarking and policy discussions: prevalence indicators, common clinical contexts that trigger the code, documentation expectations, and implications for utilization management. The publication also summarizes relevant coding relationships and operational considerations where data are available.

This summary is written for a national audience and provides the context needed by clinicians, coders, compliance officers, and payers to understand the purpose of HCPCS Level II code M1209, how it is applied, and the types of quality and safety reviews it informs.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareM1209HCPCS Level IImedication safetyhigh-risk medicationsprescribing oversightoutpatient carelong-term careutilization managementquality measurement

Billing Code Overview

HCPCS Level II code M1209 indicates at least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses. This code captures instances where multiple prescriptions for drugs within the same high-risk class are ordered without documented diagnoses that justify concurrent use.

Service type: Medication safety review / prescribing oversight

Typical site of service: Outpatient clinics, ambulatory care settings, long-term care facilities, and other settings where medication orders are managed or reviewed

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult primary care or geriatric medicine patient receiving medication management for chronic conditions. During a medication reconciliation visit or medication therapy management encounter, the clinician identifies at least two active prescriptions from the same high-risk drug class (for example, two benzodiazepines or two anticholinergic agents) without an appropriate documented diagnosis that justifies combined use. The workflow begins when the clinician or pharmacist reviews the medication list, confirms active orders in the electronic health record, documents the lack of a supporting diagnosis or indication, and records the clinical rationale and plan. Encounter documentation includes medication names, dosages, start dates, prescribers, assessment of risk (adverse effects, interactions, duplicative therapy), and communication with prescribing clinicians or the patient. Typical sites of service are outpatient primary care clinics, geriatric clinics, ambulatory pharmacy consultation settings, and transitions-of-care visits where medication lists are reconciled after hospital discharge.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when documentation supports substantially greater effort or complexity for the medication reconciliation or counseling encounter beyond typical expectations.

HCPCS M1399: Patient Leaves Practice During Follow-Up

HCPCS-M1457-ASTHMA-DIAGNOSIS-DOCUMENTATION

HCPCS Level II M1457: Asthma Diagnosis Documentation

HCPCS-M1442-TELEHEALTH-ENCOUNTER-VISIT-VIRTUAL-CARE

HCPCS Level II M1442: Telehealth Encounter / Virtual Visit

HCPCS-M1352-SUICIDAL-IDEATION-BEHAVIOR-C-SSRS-ASSESSMENT

HCPCS M1352: Suicidal Ideation and Behavior Assessment

HCPCS-M1417-COVID19-VACCINATION-STATUS-UP-TO-DATE

HCPCS Level II M1417: COVID-19 Vaccination Status, Up to Date

HCPCS-M1152-HEART-TRANSPLANT-LVAD-PATIENT

HCPCS M1152: Heart Transplant or LVAD Patient

HCPCS-M1302-DIGITAL-BREAST-TOMOSYNTHESIS-RESULTS-REVIEWED

HCPCS M1302: Digital/3D Mammography Results Documented and Reviewed

HCPCS-M1149-NECK-PROM-UNABLE-TO-COMPLETE-DUE-TO-BARRIERS

HCPCS M1149: Neck PROM Not Completed Due to Patient Barriers

HCPCS-M1454-NEW-CIED-CLINICAL-ITEM-DEVICE

HCPCS M1454: New Clinical Item or Device

HCPCS-M1205-ITCH-SEVERITY-IMPROVEMENT-ASSESSMENT

HCPCS M1205: Itch Severity Improvement Assessment

Showing 1–10 of 356

23

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary care clinicians frequently perform medication reconciliation and identify duplicative high-risk medications.
`207R00000X`	Internal Medicine	Internists manage complex chronic disease medication lists and document indications.
`207QG0300X`	Geriatric Medicine	Geriatricians commonly evaluate polypharmacy and high-risk medication duplication in older adults.
`1835G0001X`	Clinical Pharmacist	Pharmacists provide medication therapy management and detailed reconciliation services.
`208D00000X`	Psychiatry	Psychiatrists may prescribe high-risk psychotropic medications and reconcile concurrent agents.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F13.20`	Sedative, hypnotic or anxiolytic dependence, uncomplicated	Patients on multiple benzodiazepines or sedative-hypnotics may be at risk; supports evaluation of duplication.
`F41.9`	Anxiety disorder, unspecified	May be an indication for benzodiazepines but requires documentation if multiple agents are prescribed.
`G47.00`	Insomnia, unspecified	Common indication for hypnotics; duplication increases adverse effect risk, requiring reconciliation.
`M54.5`	Low back pain	Chronic pain conditions often lead to multiple central nervous system-active prescriptions; documents indications for co-prescribing.
`F11.20`	Opioid dependence, uncomplicated	Concurrent high-risk CNS depressants with opioids are clinically significant and must be justified.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99406`	Smoking and tobacco use cessation counseling, intermediate, 3-10 minutes	May be performed during the same outpatient visit when addressing medication-related behavioral health risks.
`99407`	Smoking and tobacco use cessation counseling, intensive, greater than 10 minutes	Use when counseling on medication risks and cessation is extended and documented.
`99605`	Medication therapy management service(s) provided by a pharmacist, initial 15 minutes, face-to-face with patient	Pharmacist-provided medication therapy management to identify high-risk medication duplication and document lack of indication.
`99606`	Medication therapy management service(s) provided by a pharmacist, each additional 15 minutes	Use for time beyond the initial 15 minutes spent on medication review and intervention.
`99495`	Transitional care management services with moderate complexity medical decision making	May be billed when medication reconciliation after discharge identifies high-risk duplicate therapy as part of transition care.
`99496`	Transitional care management services with high complexity medical decision making	Use when medication issues substantially increase complexity during transitions of care.

OpenPayer